Loss of Strength and Functional Decline in Duchenne's Dystrophy
- 1 July 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 38 (7), 406-411
- https://doi.org/10.1001/archneur.1981.00510070040004
Abstract
• Clinical tests of strength and function were performed on 27 ambulatory patients with Duchenne's dystrophy every three months for 21/2 years. Linear decline of strength remains a fundamental characteristic of Duchenne's dystrophy. Although generally considered a homogeneous disease, our patients showed a broad spectrum of disability. Current tests of functional ability are poor measures of disease progression during most of the ambulatory period, since efficiency is maintained despite continuous decline in muscle strength. However, after this "latent" phase, failure of certain functions paralleled muscle deterioration closely, since task loss occurred within a narrow range of composite muscle strength. Finally, data on changes in body weight showed that most patients were excessively thin rather than obese. It is concluded that manual muscle strength testing remains the most valid method of monitoring disease progression and must be included in patient assessment.This publication has 7 references indexed in Scilit:
- Treatment of Duchenne's Muscular Dystrophy With PenicillamineArchives of Neurology, 1979
- A study of possible heterogeneity in Duchenne muscular dystrophyClinical Genetics, 1979
- Lack of benefit of allopurinol in duchenne dystrophyMuscle & Nerve, 1979
- Muscle wasting and carbohydrate homeostasis in Duchenne muscular dystrophyNeurology, 1978
- Assessment of muscle strength in Duchenne muscular dystrophyNeurology, 1977
- A Study of the Reproducibility of Muscle Testing and Certain Other Aspects of Muscle Scoring*PTJ: Physical Therapy & Rehabilitation Journal, 1954
- The Role of the Physical Therapist in the Gamma Globulin Poliomyelitis Prevention Study*PTJ: Physical Therapy & Rehabilitation Journal, 1953